Corvus Pharmaceuticals Inc banner

Wall St Price Targets

C17 Price Forecast
Based on 8 analysts

+137% Upside
from €12.045 today

Corvus Pharmaceuticals Inc (C17)’s 12-month stock price forecast through August 2027 has a consensus target of €28.556, implying 137% upside. The forecast is based on price targets from 8 Wall Street analysts.

C17 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for C17 yet.

Corvus Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is C17's stock price target?
Price Target
28.556 EUR

According to Wall Street analysts, the average 1-year price target for C17 is 28.556 EUR with a low forecast of 23.858 EUR and a high forecast of 38.583 EUR.

Back to Top